
Shanthi Mogali MD
Addiction
Director of Psychiatry at Mountainside Treatment Center, Instructor of Clinical Psychiatry at Columbia University/NYSPI
Join to View Full Profile
1051 Riverside DrNew York, NY 10032
Phone+1 646-774-6147
Dr. Mogali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteFellowship, Addiction Psychiatry, 2009 - 2011
Emory University School of MedicineResidency, Psychiatry, 2005 - 2009
Fisk UniversityBA, Biology, 2001 - 2005
Meharry Medical CollegeClass of 2005
Certifications & Licensure
MA State Medical License 2014 - 2027
CT State Medical License 2014 - 2026
NY State Medical License 2009 - 2026
RI State Medical License 2022 - 2026
GA State Medical License 2008 - 2012
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry
Awards, Honors, & Recognition
- Outstanding Resident Award Nominee Indo-American Psychiatric Association, 2008
- Merit Based General Endowed Scholarship 2002
Publications & Presentations
PubMed
- 6 citationsGabapentin increases the abuse liability of alcohol alone and in combination with oxycodone in participants with co-occurring opioid and alcohol use disorder.F Castillo, J D Jones, R R Luba, S Mogali, R W Foltin
Pharmacology, Biochemistry, and Behavior. 2022-11-01 - 2 citationsThe effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and ...Jermaine D Jones, Mudassir Mumtaz, Nehal P Vadhan, Suky Martinez, Satadru Pramanik
Behavioural Pharmacology. 2022-06-01 - 14 citationsMinocycline attenuates oxycodone-induced positive subjective responses in non-dependent, recreational opioid users.Shanthi Mogali, Paula Askalsky, G. Madera, Jermaine D. Jones, Sandra D. Comer
Pharmacology, Biochemistry, and Behavior. 2021-10-01
Journal Articles
- Pioglitazone, a PPARy agonist, reduces nicotine craving in humans with marginal effects on abuse potentialJones JD, Comer SD, Metz VE, Manubay JM, Mogali S, Ciccocioppo R, Martinez S, Mumataz M, Bisaga A, Pharmacol Biochem Behav, 1/8/2017
- Abuse liability of intravenous buprenorphine vs buprenorphine/naloxone: Importance of absolute naloxone amountJones JD, Manubay JM, Mogali S, Metz VE, Madera G, Martines S, Mumtaz M, Comer SD, Drug Alcohol Depend, 1/1/2017
- Ab Initio Analysis of Lithium DimethylaminoborohydrideMogali S, Darville K, Pratt L, Journal of Organic Chemistry, 1/1/2001
Books/Book Chapters
Abstracts/Posters
- The Effects of Minocycline on Oxycodone-Induced Responses.Mogali S, Paula Askalsky, Jessica Fogel, Gabriela Madera, Jermaine Jones, Maria Sullivan, Jeanne Manubay, Sandra Comer, Experimental Biology, Boston, MA, 1/20/2013
- Effects of Minocycline on Oxycodone-Induced Responses.Mogali S, Comer SD, College on Problems of Drug Dependence, San Diego, CA, 1/15/2013
- Naltrexone reduces the subjective effects of oral d-amphetamine but not smoked cocaine in humans.Mogali S, Comer SD, Saccone PA, Roux P, Jones JD, Cooper SZ, Vosburg SK, Sullivan MA Rubin E, Manubay JM, Martinez DM, Walker EA, Haney M, Foltin RW, College on Problems of Drug Dependence, Palm Spring, CA, 1/9/2012
Press Mentions
Here's How to Know if Your Winter Blues Are More Serious Than You ThinkNovember 20th, 2017
What Does High-Risk Drinking Really Look Like?August 24th, 2017
What You Should Know About SAD and Chronic PainFebruary 17th, 2017
Research History
- T32 Research Fellow, Columbia University2009 - 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









